Three-dimensional computed tomography analysis of frontal recess cells according to the International Frontal Sinus Anatomy Classification (IFAC) - difficulties in identification of frontal recess cells in patients with diffuse primary chronic rhinosinusitis?


Journal

Otolaryngologia polska = The Polish otolaryngology
ISSN: 2300-8423
Titre abrégé: Otolaryngol Pol
Pays: Poland
ID NLM: 0404453

Informations de publication

Date de publication:
14 Jan 2022
Historique:
entrez: 29 4 2022
pubmed: 30 4 2022
medline: 3 5 2022
Statut: ppublish

Résumé

<br><b>Introduction:</b>The International Frontal Sinus Anatomy Classification (IFAC) is a consensus document created to standardize and specify the naming of cells within the region of the frontal recess and frontal sinus.</br> <br><b>Aim:</b> The aim of this study was to analyze the difficulties in identifying cells according to the IFAC in patients with diffuse primary chronic rhinosinusitis.</br> <br><b>Material and methods:</b> Three independent reviewers examined triplanar computed tomography (CT) scans to assess the anatomy of the frontal recess using the IFAC system. CT scans were chosen randomly and divided into 3 groups: CT scans of patients not presenting sinus complaints (control group), CT scans of patients affected by diffuse primary chronic rhinosinusitis non-type 2, and CT scans of patients affected by diffuse primary chronic rhinosinusitis type 2.</br> <br><b>Results:</b> Identification of all frontal cell types was accurate in patients not presenting sinus complaints (P-value < 0.05). Patients scoring 9 or more points in the Lund-Mackay scoring system demonstrated a statistically increased risk of improper identification of frontal recess cells (P-value < 0.0001).</br> <br><b>Conclusions:</b> Due to a large number of possible anatomical variants and changes caused by the chronic inflammatory disease, the IFAC nomenclatura is easier to apply to non-type 2 primary diffuse CRS patients with low scores in the L-M score scale than to primary diffuse type 2 CRS patients with higher M-L scores.</br&gt.

Identifiants

pubmed: 35485224
doi: 10.5604/01.3001.0015.6959
pii: 01.3001.0015.6959
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-14

Auteurs

Weronika Jaremek-Ochniak (W)

Department of Otorhinolaryngology, Czerniakowski Hospital, Warsaw, Poland.

Janusz Sierdziński (J)

Department of Medical Informatics and Telemedicine, Medical University of Warsaw, Poland.

Mariola Popko-Zagor (M)

Department of Otorhinolaryngology, Czerniakowski Hospital, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH